title: No Association between FC γ R3B Copy Number Variation and Susceptibility to Biopsy-Proven Giant Cell Arteritis.
abstract: Objective. To determine the relationship between FCGR3B gene copy number variation (CNV) and biopsy proven giant cell arteritis (GCA). Methods. FCGR3B CNV was determined in 139 Australian biopsy proven GCA patients and 162 population matched controls, using a duplex qPCR assay and RNase P as the reference gene. Copy number was determined using Copy Caller software (v.1.0, Applied Biosystems, USA). CNV genotypes were classified into 3 groups (<2, 2, 3+) for analysis purposes, and analysis was performed using logistic regression. Results. All GCA patients had a positive temporal artery biopsy, and the most common presenting symptoms were visual disturbance and temporal headache. The mean age of patients at biopsy was 74 years (range 51-94) and 88/139 (63%) were female. The frequency of low (<2) FCGR3B copy number was comparable between GCA patients (9/139 = 6.5%) and controls (10/162 = 6.2%), as was the frequency of high (3+) FCGR3B copy number (15/130 (10.8%) in GCA patients versus 13/162 (8.0%) in controls). Overall there was no evidence that FCGR3B CNV frequencies differed between GCA patients and controls (χ (2) = 0.75, df = 2, P = 0.69). Conclusion. FCGR3B CNV is not associated with GCA; however, replicate studies are required.
authors.affiliation: Rheumatology Department, The Queen Elizabeth Hospital, Woodville South, SA 5011, Australia ; The Health Observatory, Discipline of Medicine, The University of Adelaide, Adelaide, SA 5005, Australia.
authors.forename: Emma
authors.initials: E
authors.lastname: Dunstan
authors.forename: Sue
authors.initials: S
authors.lastname: Lester
authors.forename: Rachel
authors.initials: R
authors.lastname: Black
authors.forename: Maureen
authors.initials: M
authors.lastname: Rischmueller
authors.forename: Helen
authors.initials: H
authors.lastname: Chan
authors.forename: Alex W
authors.initials: AW
authors.lastname: Hewitt
authors.forename: Catherine L
authors.initials: CL
authors.lastname: Hill
references.citation: Annu Rev Med. 2010;61:437-55
references.pmid: 20059347
references.citation: Clin Exp Rheumatol. 2009 Jan-Feb;27(1 Suppl 52):S89-94
references.pmid: 19646354
references.citation: Ann N Y Acad Sci. 2010 Jan;1183:69-88
references.pmid: 20146709
references.citation: Nat Genet. 2007 Jun;39(6):721-3
references.pmid: 17529978
references.citation: Nat Genet. 2011 Nov 13;43(12):1241-6
references.pmid: 22081228
references.citation: Int J Rheumatol. 2012;2012:167096
references.pmid: 22701122
references.citation: Arthritis Res Ther. 2012 Feb 07;14(1):R28
references.pmid: 22309893
references.citation: Nat Med. 2011 Nov 07;17(11):1381-90
references.pmid: 22064428
references.citation: Clin Immunol Immunopathol. 1994 Feb;70(2):91-8
references.pmid: 8299234
references.citation: Nat Rev Immunol. 2008 Jan;8(1):34-47
references.pmid: 18064051
references.citation: Int Immunol. 2010 Jan;22(1):45-51
references.pmid: 19946017
references.citation: Expert Rev Clin Immunol. 2010 Nov;6(6):913-28
references.pmid: 20979556
references.citation: Genes Immun. 2012 Sep;13(6):458-60
references.pmid: 22551723
references.citation: J Rheumatol. 2012 Nov;39(11):2142-7
references.pmid: 22942264
references.citation: J Clin Invest. 1992 Dec;90(6):2355-61
references.pmid: 1469092
references.citation: Hum Mol Genet. 2010 Aug 15;19(16):3282-94
references.pmid: 20508037
references.citation: Autoimmun Rev. 2012 May;11(6-7):A544-54
references.pmid: 22285588
references.citation: Hum Mol Genet. 2012 May 15;21(10):2370-6
references.pmid: 22337955
references.citation: Arthritis Res Ther. 2006;8(4):R109
references.pmid: 16846526
references.citation: Genes Immun. 2010 Mar;11(2):155-60
references.pmid: 19741716
references.citation: Hum Mutat. 2009 May;30(5):E640-50
references.pmid: 19309690
references.citation: J Exp Med. 2008 Jul 7;205(7):1573-82
references.pmid: 18559452
references.citation: Ann Rheum Dis. 2010 Sep;69(9):1711-6
references.pmid: 20472591